Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Changes in intestinal flora in patients with type 2 diabetes on a low‑fat diet during 6 months of follow‑up

  • Authors:
    • Chengguo Liu
    • Wei Shao
    • Ming Gao
    • Jinyao Liu
    • Qiongyao Guo
    • Jie Jin
    • Fei Meng
  • View Affiliations / Copyright

    Affiliations: Department of Endocrinology, Zhoushan Putuo District People's Hospital, Zhoushan, Zhejiang 316199, P.R. China, Department of Gastroenterology, Zhoushan Putuo District People's Hospital, Zhoushan, Zhejiang 316199, P.R. China, Department of General Surgery, Zhoushan Putuo District People's Hospital, Zhoushan, Zhejiang 316199, P.R. China, Department of Research Service, Zhiyuan Medical Inspection Institute Co., Ltd, Hangzhou, Zhejiang 310006, P.R. China
    Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 40
    |
    Published online on: September 1, 2020
       https://doi.org/10.3892/etm.2020.9167
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Type 2 diabetes mellitus (T2DM) is closely associated with changes in the composition of the gut microbiota. To date, studies on the gut microbiota have focused on the genus‑level composition and microbial gene sets, whereas changes in the microbiota after clinical treatment have remained largely elusive. In the present study, 16 subjects with T2DM were enrolled and treated long‑term with a low‑fat diet. Stool samples were collected at the initial diagnosis and after 1, 3 and 6 months of treatment, and named as group T0, T1, T2 and T3, respectively. Simultaneously, stool samples from 16 healthy individuals were collected as a control (group C). In addition, 16S ribosomal RNA sequencing was performed to detect differences in the microbiota between the groups. Following the low‑fat diet treatment, the patients' fasting plasma glucose, plasma glucose 2 h after challenge, glycosylated haemoglobin A1c and body mass index (BMI) decreased significantly. The composition of the phylum in patients with type 2 diabetes mellitus was similar to that in healthy individuals. A total of 23 genera from four phyla, namely Firmicutes, Proteobacteria, Bacteroidetes and Actinobacteria, were determined to be different between group T0 and group C, while only 8 genera were different between group T3 and group C. Repeated analysis of variance suggested a complex change during the low‑fat diet treatment. The butyrate‑producing bacteria Anaerotruncus exhibited a slight increase, while Roseburia was significantly increased at the T1 stage but then gradually decreased at the later stage. In summary, a low‑fat diet was effective for patients with T2DM in reducing blood glucose and the BMI, and, to a certain extent, improving the intestinal flora to reach a normal composition. The study was registered in the Chinese Clinical Trial Registry (ChiCTR; registration no. ChiCTR1900028663).
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

American Diabetes Association. The prevention or delay of type 2 diabetes. Diabetes Care. 25:742–749. 2002.

2 

Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, et al: Prevalence and ethnic pattern of diabetes and prediabetes in china in 2013. JAMA. 317:2515–2523. 2017.PubMed/NCBI View Article : Google Scholar

3 

Li H, Gan W, Lu L, Dong X, Han X, Hu C, Yang Z, Sun L, Bao W, Li P, et al: A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes. 62:291–298. 2013.PubMed/NCBI View Article : Google Scholar

4 

Sami W, Ansari T, Butt NS and Hamid MRA: Effect of diet on type 2 diabetes mellitus: A review. Int J Health Sci (Qassim). 11:65–71. 2017.PubMed/NCBI View Article : Google Scholar

5 

Lee MS: ED 05-2 Interaction of gut dysbiosis and innate immune dysfunction in the development of metabolic syndrome. J Hypertension. 34(e187)2016.

6 

Soare A, Khazrai YM, Del Toro R, Roncella E, Fontana L, Fallucca S, Angeletti S, Formisano V, Capata F, Ruiz V, et al: The effect of the macrobiotic Ma-Pi 2 diet vs the recommended diet in the management of type 2 diabetes: The randomized controlled MADIAB trial. Nutr Metab (Lond). 25(39)2014.PubMed/NCBI View Article : Google Scholar

7 

Victoria JV, Valentine RJ, Wilund KR, Antao N, Baynard T and Woods JA: Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. Am J Physiol Endocrinol Metab. 296:E1164–E1171. 2009.PubMed/NCBI View Article : Google Scholar

8 

Zhao L: The gut microbiota and obesity: From correlation to causality. Nat Rev Microbiol. 11:639–647. 2013.PubMed/NCBI View Article : Google Scholar

9 

Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, Forslund K, Hildebrand F, Prifti E, Falony G, et al: Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 535(376)2016.PubMed/NCBI View Article : Google Scholar

10 

Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J and Bäckhed F: Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 498:99–103. 2013.PubMed/NCBI View Article : Google Scholar

11 

Ley RE, Turnbaugh PJ, Klein S and Gordon JI: Microbial ecology: Human gut microbes associated with obesity. Nature. 444:1022–1023. 2006.PubMed/NCBI View Article : Google Scholar

12 

Wirth R, Bódi N, Maróti G, Bagyánszki M, Talapka P, Fekete É, Bagi Z and Kovács KL: Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabete. PLoS One. 9(e110440)2014.PubMed/NCBI View Article : Google Scholar

13 

Heinritz SN, Weiss E, Eklund M, Aumiller T, Louis S, Rings A, Messner S, Camarinha-Silva A, Seifert J, Bischoff SC and Mosenthin R: Intestinal Microbiota and microbial metabolites are changed in a pig model fed a High-Fat/Low-Fiber or a Low-Fat/High-Fiber diet. PLoS One. 11(e0154329)2016.PubMed/NCBI View Article : Google Scholar

14 

Zhao LP, Zhang F, Ding XY, Wu GJ, Lam YY, Wang XJ, Fu HQ, Xue XH, Lu CH, Ma JL, et al: Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Sience. 359:1151–1156. 2018.PubMed/NCBI View Article : Google Scholar

15 

World Health Organization: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation, 2006.

16 

Yan Z, Tao ZH and Xiang F: Diabetics diets and their nutritional analyses. J Res Dietet Sci Culture. 32:51–53. 2015.

17 

Cheng YY: Brief Introduction of the 2013 revision of ‘Reference Intake of Dietary Nutrients of Chinese Residents’. Acta Nutrimenta Sinia. 36:313–317. 2014.

18 

Ismaiel M, Yang H and Min C: Dietary fiber role in type 2 diabetes prevention. Br Food J. 118:961–975. 2016.

19 

Lin L, Wen ZB, Lin DJ, Dong JT, Jin J and Meng F: Correlations between microbial communities in stool and clinical indicators in patients with metabolic syndrome. World J Clin Cases. 6:54–63. 2018.PubMed/NCBI View Article : Google Scholar

20 

Edgar RC: Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 26:2460–2461. 2010.PubMed/NCBI View Article : Google Scholar

21 

Qin JJ, Li YR, Cai ZM, Li SH, Zhu JF, Zhang F, Liang SS, Zhang WW, Guan YL, Shen DQ, et al: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 490:55–60. 2012.PubMed/NCBI View Article : Google Scholar

22 

Cann I, Bernardi RC and Mackie RI: Cellulose degradation in the human gut: Ruminococcus champanellensis expands the cellulosome paradigm. Environ Microbiol. 18:307–310. 2016.PubMed/NCBI View Article : Google Scholar

23 

Jones N: Gut study divides people into three types. Nature: 20 April, 2011 doi: 10.1038/news.2011.249.

24 

Cherdyntseva TA, Kotova IB and Netrusov AI: Gut study divides people into three types. Adv Exp Med Biol. 897:103–111. 2015.

25 

Sedighi M, Razavi S, Navab-Moghadam F, Khamseh ME, Alaei-Shahmiri F, Mehrtash A and Amirmozafari N: Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microb Pathog. 111:362–369. 2017.PubMed/NCBI View Article : Google Scholar

26 

Morrison DJ, Mackay WG, Edwards CA, Morrison DJ, Mackay WG, Edwards CA, Preston T and Weaver LT: Butyrate production from oligofructose fermentation by the human faecal flora: What is the contribution of extracellular acetate and lactate? Br J Nutr. 96:570–577. 2006.PubMed/NCBI

27 

Patterson E, Marques TM, O'Sullivan O, Fitzgerald P, Fitzgerald GF, Cotter PD, Dinan TG, Cryan JF, Stanton C and Ross RP: Streptozotocin-induced type-1-diabetes disease onset in Sprague-Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity. Microbiology. 161:182–193. 2015.PubMed/NCBI View Article : Google Scholar

28 

Polansky O, Sekelova Z, Faldynova M, Sebkova A, Sisak F and Rychlik I: Important metabolic pathways and biological processes expressed by chicken Cecal microbiota. Appl Environ Microbiol. 82:1569–1576. 2016.PubMed/NCBI View Article : Google Scholar

29 

Ijaz MU, Ahmed MI, Zou X, Hussain M, Zhang M, Zhao F, Xu X, Zhou G and Li C: Beef, casein, and soy proteins differentially affect lipid metabolism, triglycerides accumulation and gut microbiota of high-fat Diet-Fed C57BL/6J Mice. Front Microbiol. 9(2200)2018.PubMed/NCBI View Article : Google Scholar

30 

Louis P and Flint HJ: Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett. 294:1–8. 2009.PubMed/NCBI View Article : Google Scholar

31 

Devillard E, McIntosh FM, Duncan SH and Wallace RJ: Metabolism of linoleic acid by human gut bacteria: Different routes for biosynthesis of conjugated linoleic acid. J Bacteriol. 189:2566–2570. 2007.PubMed/NCBI View Article : Google Scholar

32 

Haro C, Montes-Borrego M, Rangel-Zúñiga OA, Alcalá-Díaz JF, Gómez-Delgado F, Pérez-Martínez P, Delgado-Lista J, Quintana-Navarro GM, Tinahones FJ, Landa BB, et al: Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population. J Clin Endocrinol Metab. 101:233–242. 2016.PubMed/NCBI View Article : Google Scholar

33 

Cantu-Jungles TM, Ruthes AC, El-Hindawy M, Moreno RB, Zhang X, Cordeiro LMC, Hamaker BR and Iacomini M: In vitro fermentation of Cookeina speciosa glucans stimulates the growth of the butyrogenic Clostridium cluster XIVa in a targeted way. Carbohydr Polym. 183:219–229. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu C, Shao W, Gao M, Liu J, Guo Q, Jin J and Meng F: Changes in intestinal flora in patients with type 2 diabetes on a low‑fat diet during 6 months of follow‑up. Exp Ther Med 20: 40, 2020.
APA
Liu, C., Shao, W., Gao, M., Liu, J., Guo, Q., Jin, J., & Meng, F. (2020). Changes in intestinal flora in patients with type 2 diabetes on a low‑fat diet during 6 months of follow‑up. Experimental and Therapeutic Medicine, 20, 40. https://doi.org/10.3892/etm.2020.9167
MLA
Liu, C., Shao, W., Gao, M., Liu, J., Guo, Q., Jin, J., Meng, F."Changes in intestinal flora in patients with type 2 diabetes on a low‑fat diet during 6 months of follow‑up". Experimental and Therapeutic Medicine 20.5 (2020): 40.
Chicago
Liu, C., Shao, W., Gao, M., Liu, J., Guo, Q., Jin, J., Meng, F."Changes in intestinal flora in patients with type 2 diabetes on a low‑fat diet during 6 months of follow‑up". Experimental and Therapeutic Medicine 20, no. 5 (2020): 40. https://doi.org/10.3892/etm.2020.9167
Copy and paste a formatted citation
x
Spandidos Publications style
Liu C, Shao W, Gao M, Liu J, Guo Q, Jin J and Meng F: Changes in intestinal flora in patients with type 2 diabetes on a low‑fat diet during 6 months of follow‑up. Exp Ther Med 20: 40, 2020.
APA
Liu, C., Shao, W., Gao, M., Liu, J., Guo, Q., Jin, J., & Meng, F. (2020). Changes in intestinal flora in patients with type 2 diabetes on a low‑fat diet during 6 months of follow‑up. Experimental and Therapeutic Medicine, 20, 40. https://doi.org/10.3892/etm.2020.9167
MLA
Liu, C., Shao, W., Gao, M., Liu, J., Guo, Q., Jin, J., Meng, F."Changes in intestinal flora in patients with type 2 diabetes on a low‑fat diet during 6 months of follow‑up". Experimental and Therapeutic Medicine 20.5 (2020): 40.
Chicago
Liu, C., Shao, W., Gao, M., Liu, J., Guo, Q., Jin, J., Meng, F."Changes in intestinal flora in patients with type 2 diabetes on a low‑fat diet during 6 months of follow‑up". Experimental and Therapeutic Medicine 20, no. 5 (2020): 40. https://doi.org/10.3892/etm.2020.9167
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team